Technology

AddToAny

Google+ Facebook Twitter Twitter

Diagnostics range launch

Horiba Medical UK has announced a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

Marking a milestone in its new product development programme, the Yumizen G range extends Horiba Medical’s Haematology portfolio into the complementary field of Haemostasis – a new discipline for the company.

Horiba Medical has developed a reputation for expertise and excellence in blood cell analysis. This has been utilised to deliver the new and comprehensive range of Yumizen G systems and reagents for coagulation diagnostics.

Cleve Wright, Director of Horiba Medical UK, said: “By leveraging our extensive expertise in the Haematology field, we have significantly broadened our scope in blood disease analysis into a complementary discipline.”

horiba.com/uk/medical

Related Articles

How to… ensure effective blood stock management

Clare Denison and Fatts Chowdhury outline the Blood Stocks Management Scheme and explain how it can reduce wastage and save money.

Laboratory diagnostic test enters clinical practice

A blood test that improves the management pre-eclampsia has been introduced into routine practice, write Laboratory Manager Tim James and Consultant Obstetrician Manu Vatish.

Cutting-edge research pt.3

The IBMS has awarded five research grants this year. Here the final two successful candidates outline the work that they are undertaking.

Magnetic blood filtration

Medical device firm MediSieve was shortlisted for this year’s Hammersmith and Fulham Brilliant Business Awards.

Top